Report Detail
Global (United States, European Union and China) Human Chorionic Gonadotropin (HCG) Market Research Report 2019-2025
- RnM3664219 |
- 13 August, 2019 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
Human chorionic gonadotropin (HCG) is a female hormone produced by the placenta after implantation of the egg, which is why it can be detected in a few pregnancy tests. In addition, it can be extracted from the urine of pregnant women or produced from cultures of genetically modified cells using recombinant DNA technology.
The major factors that fuel the growth of the market are the rising incidence of infertility issues among men and women, along with the increasing maternity age among women. In addition, the rising preference for hormonal drug therapy supplements the market growth.
In 2019, the market size of Human Chorionic Gonadotropin (HCG) is 390 million US$ and it will reach 620 million US$ in 2025, growing at a CAGR of 6.0% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Human Chorionic Gonadotropin (HCG).
This report studies the global market size of Human Chorionic Gonadotropin (HCG), especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Human Chorionic Gonadotropin (HCG) sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
EMD Serono, Inc
Ferring B.V
Merck & Co., Inc
Bristol Myers Squibb Company
Fresenius Kabi AG, LLC
Scrippslabs
Leebio
Kamiya Biomedical Company
Sanzyme
Cigna
Market Segment by Product Type
Natural Source Extraction
Recombinant DNA Technology
Market Segment by Application
Female Infertility Treatment
Oligospermic Treatment
Cryptorchidism Treatment
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Human Chorionic Gonadotropin (HCG) status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Human Chorionic Gonadotropin (HCG) manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Human Chorionic Gonadotropin (HCG) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Human Chorionic Gonadotropin (HCG) Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Natural Source Extraction
- 1.3.3 Recombinant DNA Technology
- 1.4 Market Segment by Application
- 1.4.1 Global Human Chorionic Gonadotropin (HCG) Market Share by Application (2019-2025)
- 1.4.2 Female Infertility Treatment
- 1.4.3 Oligospermic Treatment
- 1.4.4 Cryptorchidism Treatment
- 1.4.5 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Human Chorionic Gonadotropin (HCG) Market Size
- 2.1.1 Global Human Chorionic Gonadotropin (HCG) Revenue 2014-2025
- 2.1.2 Global Human Chorionic Gonadotropin (HCG) Sales 2014-2025
- 2.2 Human Chorionic Gonadotropin (HCG) Growth Rate by Regions
- 2.2.1 Global Human Chorionic Gonadotropin (HCG) Sales by Regions 2014-2019
- 2.2.2 Global Human Chorionic Gonadotropin (HCG) Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Human Chorionic Gonadotropin (HCG) Sales by Manufacturers
- 3.1.1 Human Chorionic Gonadotropin (HCG) Sales by Manufacturers 2014-2019
- 3.1.2 Human Chorionic Gonadotropin (HCG) Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Human Chorionic Gonadotropin (HCG) Revenue by Manufacturers (2014-2019)
- 3.2.2 Human Chorionic Gonadotropin (HCG) Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Human Chorionic Gonadotropin (HCG) Market Concentration Ratio (CR5 and HHI)
- 3.3 Human Chorionic Gonadotropin (HCG) Price by Manufacturers
- 3.4 Key Manufacturers Human Chorionic Gonadotropin (HCG) Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Human Chorionic Gonadotropin (HCG) Market
- 3.6 Key Manufacturers Human Chorionic Gonadotropin (HCG) Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Natural Source Extraction Sales and Revenue (2014-2019)
- 4.1.2 Recombinant DNA Technology Sales and Revenue (2014-2019)
- 4.2 Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Type
- 4.3 Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Type
- 4.4 Human Chorionic Gonadotropin (HCG) Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Human Chorionic Gonadotropin (HCG) Sales by Application
6 United States
- 6.1 United States Human Chorionic Gonadotropin (HCG) Breakdown Data by Company
- 6.2 United States Human Chorionic Gonadotropin (HCG) Breakdown Data by Type
- 6.3 United States Human Chorionic Gonadotropin (HCG) Breakdown Data by Application
7 European Union
- 7.1 European Union Human Chorionic Gonadotropin (HCG) Breakdown Data by Company
- 7.2 European Union Human Chorionic Gonadotropin (HCG) Breakdown Data by Type
- 7.3 European Union Human Chorionic Gonadotropin (HCG) Breakdown Data by Application
8 China
- 8.1 China Human Chorionic Gonadotropin (HCG) Breakdown Data by Company
- 8.2 China Human Chorionic Gonadotropin (HCG) Breakdown Data by Type
- 8.3 China Human Chorionic Gonadotropin (HCG) Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Human Chorionic Gonadotropin (HCG) Breakdown Data by Company
- 9.2 Rest of World Human Chorionic Gonadotropin (HCG) Breakdown Data by Type
- 9.3 Rest of World Human Chorionic Gonadotropin (HCG) Breakdown Data by Application
- 9.4 Rest of World Human Chorionic Gonadotropin (HCG) Breakdown Data by Countries
- 9.4.1 Rest of World Human Chorionic Gonadotropin (HCG) Sales by Countries
- 9.4.2 Rest of World Human Chorionic Gonadotropin (HCG) Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 EMD Serono, Inc
- 10.1.1 EMD Serono, Inc Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Human Chorionic Gonadotropin (HCG)
- 10.1.4 Human Chorionic Gonadotropin (HCG) Product Introduction
- 10.1.5 EMD Serono, Inc Recent Development
- 10.2 Ferring B.V
- 10.2.1 Ferring B.V Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Human Chorionic Gonadotropin (HCG)
- 10.2.4 Human Chorionic Gonadotropin (HCG) Product Introduction
- 10.2.5 Ferring B.V Recent Development
- 10.3 Merck & Co., Inc
- 10.3.1 Merck & Co., Inc Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Human Chorionic Gonadotropin (HCG)
- 10.3.4 Human Chorionic Gonadotropin (HCG) Product Introduction
- 10.3.5 Merck & Co., Inc Recent Development
- 10.4 Bristol Myers Squibb Company
- 10.4.1 Bristol Myers Squibb Company Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Human Chorionic Gonadotropin (HCG)
- 10.4.4 Human Chorionic Gonadotropin (HCG) Product Introduction
- 10.4.5 Bristol Myers Squibb Company Recent Development
- 10.5 Fresenius Kabi AG, LLC
- 10.5.1 Fresenius Kabi AG, LLC Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Human Chorionic Gonadotropin (HCG)
- 10.5.4 Human Chorionic Gonadotropin (HCG) Product Introduction
- 10.5.5 Fresenius Kabi AG, LLC Recent Development
- 10.6 Scrippslabs
- 10.6.1 Scrippslabs Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Human Chorionic Gonadotropin (HCG)
- 10.6.4 Human Chorionic Gonadotropin (HCG) Product Introduction
- 10.6.5 Scrippslabs Recent Development
- 10.7 Leebio
- 10.7.1 Leebio Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Human Chorionic Gonadotropin (HCG)
- 10.7.4 Human Chorionic Gonadotropin (HCG) Product Introduction
- 10.7.5 Leebio Recent Development
- 10.8 Kamiya Biomedical Company
- 10.8.1 Kamiya Biomedical Company Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Human Chorionic Gonadotropin (HCG)
- 10.8.4 Human Chorionic Gonadotropin (HCG) Product Introduction
- 10.8.5 Kamiya Biomedical Company Recent Development
- 10.9 Sanzyme
- 10.9.1 Sanzyme Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Human Chorionic Gonadotropin (HCG)
- 10.9.4 Human Chorionic Gonadotropin (HCG) Product Introduction
- 10.9.5 Sanzyme Recent Development
- 10.10 Cigna
- 10.10.1 Cigna Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Human Chorionic Gonadotropin (HCG)
- 10.10.4 Human Chorionic Gonadotropin (HCG) Product Introduction
- 10.10.5 Cigna Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Human Chorionic Gonadotropin (HCG) Sales Channels
- 11.2.2 Human Chorionic Gonadotropin (HCG) Distributors
- 11.3 Human Chorionic Gonadotropin (HCG) Customers
12 Market Forecast
- 12.1 Global Human Chorionic Gonadotropin (HCG) Sales and Revenue Forecast 2019-2025
- 12.2 Global Human Chorionic Gonadotropin (HCG) Sales Forecast by Type
- 12.3 Global Human Chorionic Gonadotropin (HCG) Sales Forecast by Application
- 12.4 Human Chorionic Gonadotropin (HCG) Forecast by Regions
- 12.4.1 Global Human Chorionic Gonadotropin (HCG) Sales Forecast by Regions 2019-2025
- 12.4.2 Global Human Chorionic Gonadotropin (HCG) Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Human Chorionic Gonadotropin (HCG). Industry analysis & Market Report on Human Chorionic Gonadotropin (HCG) is a syndicated market report, published as Global (United States, European Union and China) Human Chorionic Gonadotropin (HCG) Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Human Chorionic Gonadotropin (HCG) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
